Matthew W Foehr's Net Worth
Matthew W Foehr's net worth is estimated to be at least $33,827,831.06 as of 11/23/2024. CoreStreet's estimation of Matthew W Foehr's net worth is based on their sale of stock and current holding of stock.
Matthew W Foehr is CEO at OmniAb Inc.. They have executed at least 38 trades of stock as per SEC Form 4 filings. Their most recent trade was for 240,000 units of OABI stock on 05/24/2024. Their biggest sale was on 02/04/2021 when they sold 44,547 units of Ligand Pharmaceuticals Incorporated stock for $7,878,582.42. They typically trade 3 times per year.
Total value of insider buys:
- $5,620,073.58
Total value of insider sells:
- $28,207,757.48
Most recent insider trade:
- May 24, 2024
Matthew W Foehr's Insider Trading History
| OmniAb Inc. | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
May 24, 2024 | CEO | 240,000 | $4.42 | Buy | $1,060,800.00 |
March 22, 2024 | CEO | 225,000 | $5.19 | Buy | $1,167,750.00 |
Nov. 10, 2023 | CEO | 95,000 | $4.27 | Buy | $405,650.00 |
Aug. 14, 2023 | CEO | 45,000 | $5.48 | Buy | $246,600.00 |
June 9, 2023 | CEO | 115,000 | $4.52 | Buy | $519,800.00 |
Dec. 12, 2022 | CEO | 150,000 | $3.77 | Buy | $565,500.00 |
Nov. 30, 2022 | CEO | 300,000 | $3.39 | Buy | $1,017,000.00 |
| Ligand Pharmaceuticals Incorporated | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
May 13, 2022 | COO | 2,500 | $82.76 | Buy | $206,900.00 |
Nov. 11, 2021 | COO | 11,160 | $163.02 | Sell | $1,819,303.20 |
Aug. 4, 2021 | COO | 8,840 | $109.67 | Sell | $969,482.80 |
Feb. 4, 2021 | COO | 44,547 | $176.86 | Sell | $7,878,582.42 |
Aug. 24, 2020 | COO | 78 | $110.89 | Sell | $8,649.42 |
Aug. 21, 2020 | COO | 7,225 | $112.88 | Sell | $815,558.00 |
Feb. 27, 2020 | COO | 1,706 | $21.92 | Buy | $37,395.52 |
Feb. 27, 2020 | COO | 7,225 | $14.47 | Buy | $104,545.75 |
Feb. 27, 2020 | COO | 7,225 | $110.00 | Sell | $794,750.00 |
Feb. 15, 2020 | COO | 869 | $97.23 | Sell | $84,492.87 |
Feb. 15, 2020 | COO | 447 | $97.23 | Sell | $43,461.81 |
Feb. 15, 2020 | COO | 1,170 | $97.23 | Sell | $113,759.10 |
Feb. 14, 2020 | COO | 7,225 | $95.84 | Sell | $692,444.00 |
Feb. 14, 2020 | COO | 7,225 | $14.47 | Buy | $104,545.75 |
Feb. 13, 2020 | COO | 496 | $21.92 | Buy | $10,872.32 |
Feb. 13, 2020 | COO | 7,396 | $0.00 | Buy | $0.00 |
Oct. 1, 2018 | COO | 12,000 | $273.88 | Sell | $3,286,560.00 |
Sept. 4, 2018 | Insider | 12,000 | $255.01 | Sell | $3,060,120.00 |
May 10, 2018 | Insider | 8,881 | $167.63 | Sell | $1,488,722.03 |
Feb. 23, 2018 | COO | 5,444 | $152.98 | Sell | $832,823.12 |
Aug. 9, 2017 | Insider | 6,100 | $127.51 | Sell | $777,811.00 |
May 12, 2017 | Insider | 5,621 | $112.20 | Sell | $630,676.20 |
March 2, 2017 | Insider | 6,879 | $103.39 | Sell | $711,219.81 |
March 17, 2016 | COO | 6,400 | $96.70 | Sell | $618,880.00 |
June 26, 2015 | COO | 12,500 | $100.97 | Sell | $1,262,125.00 |
June 22, 2015 | COO | 23,046 | $96.45 | Sell | $2,222,786.70 |
June 28, 2013 | COO | 1,059 | $17.36 | Buy | $18,384.24 |
| Viking Therapeutics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
June 10, 2021 | Director | 20,000 | $5.69 | Buy | $113,800.00 |
June 30, 2020 | Director | 13,000 | $7.35 | Sell | $95,550.00 |
Nov. 15, 2016 | Director | 13,000 | $1.21 | Buy | $15,730.00 |
April 13, 2016 | Director | 20,000 | $1.24 | Buy | $24,800.00 |